Evogene Ltd. (EVGN.TA)
ILA 389.0
(1.09%)
ILA 389.0
(1.09%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.64 Million | 1.67 Million | 930 Thousand | 1.04 Million | 753 Thousand | 1.74 Million |
| Cost of Revenue | 1.69 Million | 909 Thousand | 767 Thousand | 574 Thousand | 334 Thousand | 1.45 Million |
| Gross Profit | 3.94 Million | 766 Thousand | 163 Thousand | 466 Thousand | 419 Thousand | 295 Thousand |
| Operating Expenses | 30.45 Million | 27.7 Million | 31.11 Million | 25.28 Million | 21.58 Million | 20.28 Million |
| Selling, General and Administrative Expenses | 9.67 Million | 10.41 Million | 7.25 Million | 5.32 Million | 3.76 Million | 3.51 Million |
| Research and Development Expenses | 20.77 Million | 20.79 Million | 23.86 Million | 19.95 Million | 17.82 Million | 16.77 Million |
| Other Expenses | - | -3.5 Million | - | - | -41 Thousand | -120 Thousand |
| Cost and Expenses | 32.14 Million | 28.61 Million | 31.88 Million | 25.85 Million | 21.91 Million | 21.73 Million |
| Operating Income | -26.5 Million | -26.94 Million | -30.95 Million | -24.81 Million | -21.16 Million | -19.98 Million |
| Interest Expense | 115 Thousand | 3.32 Million | 1.41 Million | 2.95 Million | 386 Thousand | 2.2 Million |
| Income Tax Expense | -33 Thousand | 90 Thousand | 13 Thousand | 32 Thousand | 24 Thousand | 30 Thousand |
| Earnings before Tax | -25.98 Million | -29.75 Million | -30.43 Million | -26.17 Million | -19.09 Million | -20.78 Million |
| Net Income | -23.87 Million | -29.84 Million | -30.44 Million | -26.2 Million | -19.11 Million | -20.75 Million |
| Earnings Per Share Basic | -0.52 | -0.72 | -0.75 | -0.93 | -0.74 | -0.81 |
| Earnings Per Share Diluted | -0.52 | -0.72 | -0.75 | -0.93 | -0.74 | -0.81 |
| Weighted Average Shares Outstanding | 45.68 Million | 41.21 Million | 40.43 Million | 28.15 Million | 25.75 Million | 25.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.68 Million | 41.21 Million | 40.43 Million | 28.15 Million | 25.75 Million | 25.75 Million |
| Gross Margin | 0.70 | 0.46 | 0.18 | 0.45 | 0.56 | 0.17 |
| EBIT Margin | -4.12 | -14.24 | -28.80 | -19.71 | -21.16 | -9.48 |
| Profit Margin | -4.23 | -17.82 | -32.74 | -25.20 | -25.39 | -11.88 |
| EBITDA | -23.26 Million | -27 Million | -27.88 Million | -23.21 Million | -18.39 Million | -17.96 Million |
| Earnings Before Tax Margin | -4.70 | -16.08 | -33.28 | -23.86 | -28.11 | -11.44 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 914 Thousand | 4.19 Million | 578 Thousand | 5.64 Million | 3.76 Million | 654 Thousand |
| Cost of Revenue | 537 Thousand | 310 Thousand | 398 Thousand | 1.69 Million | 511 Thousand | 461 Thousand |
| Gross Profit | 377 Thousand | 3.88 Million | 180 Thousand | 3.94 Million | 3.25 Million | 193 Thousand |
| Operating Expenses | 6.47 Million | 7.96 Million | 7.8 Million | 30.45 Million | 7.43 Million | 8.09 Million |
| Selling, General and Administrative Expenses | 2.45 Million | 2.64 Million | 2.26 Million | - | 2.37 Million | 2.72 Million |
| Research and Development Expenses | 4.01 Million | 4.8 Million | 5.54 Million | - | 5.06 Million | 5.36 Million |
| Other Expenses | 5000.00 | - | - | - | - | - |
| Cost and Expenses | 7.01 Million | 8.27 Million | 8.2 Million | 32.14 Million | 7.95 Million | 8.55 Million |
| Operating Income | -6.1 Million | -4.08 Million | -7.62 Million | -26.5 Million | -4.18 Million | -7.9 Million |
| Interest Expense | 122 Thousand | 166 Thousand | -779 Thousand | 115 Thousand | 109 Thousand | 247 Thousand |
| Income Tax Expense | 1000.00 | 425 Thousand | -4000.00 | -33 Thousand | -5000.00 | 21 Thousand |
| Earnings before Tax | -5.98 Million | -3.84 Million | -7.34 Million | -25.98 Million | -3.86 Million | -7.75 Million |
| Net Income | -5.41 Million | -3.86 Million | -6.6 Million | -23.87 Million | -3.98 Million | -7.02 Million |
| Earnings Per Share Basic | -0.11 | -0.08 | -0.13 | - | -0.08 | -0.17 |
| Earnings Per Share Diluted | -0.11 | -0.08 | -0.13 | - | -0.08 | -0.17 |
| Weighted Average Shares Outstanding | 50.62 Million | 50.62 Million | 50.58 Million | 45.68 Million | 48.92 Million | 41.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 50.62 Million | 50.62 Million | 50.58 Million | 45.68 Million | 48.92 Million | 41.64 Million |
| Gross Margin | 0.41 | 0.93 | 0.31 | 0.70 | 0.86 | 0.30 |
| EBIT Margin | -5.74 | -0.72 | -12.90 | - | -0.82 | -10.49 |
| Profit Margin | -5.93 | -0.92 | -11.42 | -4.23 | -1.06 | -10.74 |
| EBITDA | -5.24 Million | -3 Million | -7.45 Million | - | -3.09 Million | -6.86 Million |
| Earnings Before Tax Margin | -6.68 | -0.98 | -13.20 | -4.70 | -1.11 | -12.08 |
SVGAF
EGIE3
002882
005180
RTOBF
TSPG